Literature DB >> 24880742

Multi-modality functional image guided dose escalation in the presence of uncertainties.

Markus Alber1, Daniela Thorwarth2.   

Abstract

BACKGROUND AND
PURPOSE: In order to increase local tumour control by radiotherapy without increasing toxicity, it appears promising to harness functional imaging (FI) to guide dose to sub-volumes of the target with a high tumour load and perhaps de-escalate dose to low risk volumes, in order to maximise the efficiency of the deposited radiation dose. METHODS AND MATERIALS: A number of problems have to be solved to make focal dose escalation (FDE) efficient and safe: (1) how to combine ambiguous information from multiple imaging modalities; (2) how to take into account uncertainties of FI based tissue classification; (3) how to account for geometric uncertainties in treatment delivery; (4) how to add complementary FI modalities to an existing scheme. A generic optimisation concept addresses these points and is explicitly designed for clinical efficacy and for lowering the implementation threshold to FI-guided FDE. It combines classic tumour control probability modelling with a multi-variate logistic regression model of FI accuracy and an uncomplicated robust optimisation method.
RESULTS: Its key elements are (1) that dose is deposited optimally when it achieves equivalent expected effect everywhere in the target volume and (2) that one needs to cap the certainty about the absence of tumour anywhere in the target region. For illustration, an example of a PET/MR-guided FDE in prostate cancer is given.
CONCLUSIONS: FDE can be safeguarded against FI uncertainties, at the price of a limit on the sensible dose escalation.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Dose painting; Functional imaging; IMRT; MRI; PET; Prostate cancer

Mesh:

Year:  2014        PMID: 24880742     DOI: 10.1016/j.radonc.2014.04.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  (18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.

Authors:  Ang Gao; Shijiang Wang; Zheng Fu; Xindong Sun; Jinming Yu; Xue Meng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.

Authors:  Liam Welsh; Rafal Panek; Dualta McQuaid; Alex Dunlop; Maria Schmidt; Angela Riddell; Dow-Mu Koh; Simon Doran; Iain Murray; Yong Du; Sue Chua; Vibeke Hansen; Kee H Wong; Jamie Dean; Sarah Gulliford; Shreerang Bhide; Martin O Leach; Christopher Nutting; Kevin Harrington; Kate Newbold
Journal:  Radiat Oncol       Date:  2015-05-15       Impact factor: 3.481

Review 3.  Functional imaging for radiotherapy treatment planning: current status and future directions-a review.

Authors:  D Thorwarth
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

Review 4.  Hypoxia imaging and radiotherapy: bridging the resolution gap.

Authors:  David Robert Grimes; Daniel R Warren; Samantha Warren
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

5.  Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Authors:  Nicole Wiedenmann; Hatice Bunea; Hans C Rischke; Andrei Bunea; Liette Majerus; Lars Bielak; Alexey Protopopov; Ute Ludwig; Martin Büchert; Christian Stoykow; Nils H Nicolay; Wolfgang A Weber; Michael Mix; Philipp T Meyer; Jürgen Hennig; Michael Bock; Anca L Grosu
Journal:  Radiat Oncol       Date:  2018-08-29       Impact factor: 3.481

6.  Uncertainty evaluation of image-based tumour control probability models in radiotherapy of prostate cancer using a visual analytic tool.

Authors:  Oscar Casares-Magaz; Renata G Raidou; Jarle Rørvik; Anna Vilanova; Ludvig P Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2018-01-12

7.  Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI.

Authors:  E J Her; A Haworth; H M Reynolds; Y Sun; A Kennedy; V Panettieri; M Bangert; S Williams; M A Ebert
Journal:  Radiat Oncol       Date:  2020-07-13       Impact factor: 3.481

8.  Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy.

Authors:  Peilin Liu; Xian-Shu Gao; Zishen Wang; Xiaomei Li; Cao Xi; Chenghao Jia; Mu Xie; Feng Lyu; Xuanfeng Ding
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

9.  The feasibility of atlas-based automatic segmentation of MRI for H&N radiotherapy planning.

Authors:  Kieran Wardman; Robin J D Prestwich; Mark J Gooding; Richard J Speight
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

10.  Biological optimization for mediastinal lymphoma radiotherapy - a preliminary study.

Authors:  Laura Ann Rechner; Arezoo Modiri; Line Bjerregaard Stick; Maja V Maraldo; Marianne C Aznar; Stephanie R Rice; Amit Sawant; Søren M Bentzen; Ivan Richter Vogelius; Lena Specht
Journal:  Acta Oncol       Date:  2020-03-27       Impact factor: 4.089

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.